Nrx pharmaceuticals, inc. (nasdaq: nrxp) and hope therapeutics, inc. announce participation at the thinkequity conference october 30, 2024

Miami, oct. 23, 2024 (globe newswire) -- nrx pharmaceuticals, inc. (nasdaq: nrxp), a clinical-stage biopharmaceutical company, (“nrx,” the “company”) and hope therapeutics, inc., a medical and technology driven company and wholly-owned subsidiary of nrx, today announced they will be featured as a participating in the thinkequity conference on october 30, 2024, at the mandarin oriental hotel in new york. the thinkequity conference gathers institutional investors, corporate clients, and other industry professionals to highlight groundbreaking innovations and financial strategies.
NRXP Ratings Summary
NRXP Quant Ranking